Latest news
Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 21:01:41 GMTHeron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 15:05:39 GMTHeron Therapeutics Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Mon, 10 Aug 2026 14:37:56 GMTHeron Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 14:04:29 GMTHeron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:10:02 GMTdevelopment in the article - MinichartMinichart · Mon, 10 Aug 2026 12:43:00 GMTHeron Therapeutics (NASDAQ:HRTX) Issues Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:41:50 GMTHeron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook - TradingViewTradingView · Mon, 10 Aug 2026 12:08:40 GMT